| Name | Tirzepatide | CAS# | 2023788-19-2 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1kg ¥Inquiry/1g ¥Inquiry/1mg ¥Inquiry/1ton | Purity | 99.0% | |
| Stocking Period |
1 Day | Stock | In Stock | |
| Product Webpage: | https://peptidee.com/index.php/product/tirzepatide/ | |||
| Detail
Product Information
Tirzepatide Sodium Overview Tirzepatide sodium, a peptide for treating type 2 diabetes, functions by mimicking the effects of incretin hormones GLP-1 and GIP. These hormones stimulate insulin release, reduce glucagon secretion, and slow gastric emptying. Used for improving blood sugar control in adults with type 2 diabetes, Tirzepatide also aids in weight loss. Administered via subcutaneous injection, it represents a significant advancement in type 2 diabetes management with its dual-action mechanism. Product Details Amino Acid Sequence:YE-Aib-GTFSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS Note:Aib is a non-coded (non-proteinogenic) amino acid – H₂H-C(CH₃)₂-COOH Molecular Formula:C₂₂₅H₃₄₈N₄₈O₆₈ Molecular Weight:527 g/mol PubChem CID:156588324 CAS Number:2023788-19-2 Research Highlights Blood Glucose Control:Tirzepatide effectively regulates blood glucose levels through dual agonism of GIP and GLP-1 receptors, crucial for insulin secretion and post-meal blood sugar management. Cardiovascular Benefits:Demonstrates the ability to improve cardiovascular health by lowering blood pressure and reducing levels of LDL cholesterol and triglycerides, suggesting a broader role in metabolic health beyond diabetes control. Important Notices: This product is sold for scientific research purposes only. |